Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.007x

Based on the latest financial reports, Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs8.20 Million ≈ $88.66K USD) by net assets (Rs1.19 Billion ≈ $12.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AAREYDRUGS equity financing ratio to measure how much of total assets are equity-financed.

Aarey Drugs & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Aarey Drugs & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check AAREYDRUGS cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Aarey Drugs & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aarey Drugs & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Prestar Resources Bhd KLSE:9873	0.038x
Goldspot Discoveries Corp V:SPOT	-0.022x
Jade Marvel Group Bhd KLSE:7043	0.010x
THE INX DIGITAL CO.INC. F:FN4	N/A
Global Vectra Helicorp Limited NSE:GLOBALVECT	-0.932x
Verena Multi Finance Tbk JK:VRNA	0.085x
Fun Yours Technology Co Ltd TWO:6482	0.043x
iBio, Inc. Common Stock NYSE MKT:IBIO	-0.101x

Annual Cash Flow Conversion Efficiency for Aarey Drugs & Pharmaceuticals Limited (2009–2025)

The table below shows the annual cash flow conversion efficiency of Aarey Drugs & Pharmaceuticals Limited from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs1.38 Billion ≈ $14.98 Million	Rs8.95 Million ≈ $96.77K	0.006x	+128.66%
2024-03-31	Rs1.33 Billion ≈ $14.36 Million	Rs-29.94 Million ≈ $-323.77K	-0.023x	-106.66%
2023-03-31	Rs1.17 Billion ≈ $12.70 Million	Rs-12.81 Million ≈ $-138.55K	-0.011x	+72.40%
2022-03-31	Rs1.14 Billion ≈ $12.29 Million	Rs-44.93 Million ≈ $-485.90K	-0.040x	-171.37%
2021-03-31	Rs988.60 Million ≈ $10.69 Million	Rs54.77 Million ≈ $592.32K	0.055x	+79.06%
2020-03-31	Rs923.46 Million ≈ $9.99 Million	Rs28.57 Million ≈ $309.00K	0.031x	+288.83%
2019-03-31	Rs865.53 Million ≈ $9.36 Million	Rs6.89 Million ≈ $74.48K	0.008x	+103.14%
2018-03-31	Rs802.45 Million ≈ $8.68 Million	Rs-203.51 Million ≈ $-2.20 Million	-0.254x	-1427.42%
2017-03-31	Rs503.60 Million ≈ $5.45 Million	Rs9.62 Million ≈ $104.05K	0.019x	-87.61%
2016-03-31	Rs366.97 Million ≈ $3.97 Million	Rs56.59 Million ≈ $612.01K	0.154x	+67.84%
2015-03-31	Rs354.09 Million ≈ $3.83 Million	Rs32.53 Million ≈ $351.84K	0.092x	+851.96%
2014-03-31	Rs345.21 Million ≈ $3.73 Million	Rs-4.22 Million ≈ $-45.62K	-0.012x	-112.13%
2013-03-31	Rs334.70 Million ≈ $3.62 Million	Rs33.72 Million ≈ $364.71K	0.101x	+136.83%
2012-03-31	Rs328.12 Million ≈ $3.55 Million	Rs-89.76 Million ≈ $-970.74K	-0.274x	+39.84%
2011-03-31	Rs219.05 Million ≈ $2.37 Million	Rs-99.61 Million ≈ $-1.08 Million	-0.455x	-254.49%
2010-03-31	Rs92.08 Million ≈ $995.81K	Rs-11.81 Million ≈ $-127.73K	-0.128x	-3666.00%
2009-03-31	Rs83.97 Million ≈ $908.15K	Rs302.06K ≈ $3.27K	0.004x	--

About Aarey Drugs & Pharmaceuticals Limited

NSE:AAREYDRUGS India Drug Manufacturers - Specialty & Generic

Market Cap

$25.00 Million

Rs2.31 Billion INR

Market Cap Rank

#24330 Global

#1349 in India

Share Price

Rs81.53

Change (1 day)

+4.71%

52-Week Range

Rs50.75 - Rs99.25

All Time High

Rs99.25